|
|
| |
|
March
15, 2006 |
| |
|
Welcome to ACAAI eNews — a bi-weekly aggregated news service
from the American College of Allergy, Asthma & Immunology. To be
removed from this distribution list, please see instructions at
bottom. |
| |
 |
Top
Stories |
|
|
|
 |
Distance Learning |
|
|
|
 |
Drugs and Devices |
|
|
|
 |
Association
News |
| |
|
 |
Fellows-in-Training |
| |
|
 |
Calendar |
| |
|
 |
Archive |
|
|
|
|
 |
FIT Archive |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Have
you had a chance to read the OIG report in its
entirety?
Do you believe that all of the recommendations made
in the Joint Taskforce on Immunotherapy and Allergy
Diagnostic Testing are applicable to your practice?
As a
result of the OIG report, what do you plan to do? |
|
 |
|
|
|
|
|
|
|
|
|
|
Distance Learning |
2005 ACAAI ANNUAL MEETING
• Symposia Online
Nov. 4-9, Anaheim
Link
2005 Board/Recertification Review Course:
DVDs, Audio CDs, MP3s
Link
ACAAI Tape Store Complete Listing
Link
2004 ACAAI ANNUAL MEETING
• Symposia Online
Nov. 12-17, Boston
Link
2003 ACAAI ANNUAL MEETING
Nov. 7-12, 2003, New Orleans • Two Symposia Online
Link
• Plenary Sessions CD-ROM and DVD
Link
Patient-Centered Allergy Practice Endorsed by ACAAI, Sponsored by Physicians Practice
Link |
Calendar |
|
APRIL
AAAAI/ACAAI Certification/Maintenance of Certification Board
Review Course
April
6-9
Westin Michigan Avenue Hotel
Chicago, Ill.
Link
Allergy and
Clinical Immunology (64th Annual)
University of Minnesota
April 7, Minneapolis
Tel: 612-626-7600 or 800-776-8636
E-mail
Link
JULY
24th Annual Aspen Allergy Conference
July
26-29, Aspen, Colo.
Contact: Kathleen Goldy
Tel: 303-282-0491
E-mail
Link
ONGOING
World Allergy Organization Society Meetings
|
Sponsored
By |
 |
|
|
|
|
|
|
|
|
| |
Top
Stories |
| |
Study: Delta FVC a better test of adolescent asthma remission
The percentage drop in forced vital capacity (delta FVC) at
the provocative concentration of methacholine causing a 20% fall
in FEV1 (PC20) can differentiate between symptomatic asthma and
clinical remission during adolescence, according to a study in
Chest. Scientists at Seoul National University Hospital
in Korea studied whether delta FVC was higher in adolescents
with symptomatic asthma (n=40) than in those with clinical
remission (n=80). The mean delta FVC of 15.5 percent in the
symptomatic group was significantly higher than the 12.8 percent
in the remission group with bronchial hyperresponsiveness or in
the 11.5 percent in the remission group without bronchial
hyperresponsiveness. Delta FVC appeared to be a better marker
for discriminating between symptomatic asthma and remission than
the PC20.

Many allergic teens gambling with food
As many as 42 percent of teenagers with food allergies admit
to risky eating habits, such as knowingly eating foods labeled
"may contain" allergens, according to a survey presented at the
2006 AAAAI Annual Meeting in Miami Beach. Researchers at Mount
Sinai School of Medicine in New York, polled 174 teenagers,
whose average age was 16 years old. They also reported that many
teens do not always carry self-injectable epinephrine. Only 43
percent reported carrying it to sports events, and less than 65
percent carry it “with friends, at school or dance events, or on
dates.” They were most likely to carry self-injectable
epinephrine when traveling (94 percent) or going out to eat (81
percent).
BMI may affect asthma drug response
A higher body mass index (BMI) in asthmatics appears to be
linked to a decreased response to inhaled corticosteroids,
according to a study in the European Respiratory Journal.
However, subjects’ response to leukotriene antagonists was
unaffected by BMI. Scientists at the University of Michigan
Health System, Ann Arbor, looked at data from four
double-blind trials in which more than 3,000 patients with
moderate asthma were randomized to montelukast sodium,
beclomethasone or placebo. Measures included days of asthma
control, lung function (FEV1) and use of a rescue inhaler.
The study was funded by Merck, manufacturer of Singulair.
Nickel, gold among top 10 contact dermatitis allergens
Nickel and gold are among the leading causes of contact
dermatitis, according to a study presented at the American
Academy of Dermatology annual meeting, in San Francisco.
Researchers at the Mayo Clinic analyzed results from contact
dermatitis testing conducted on 3,854 patients. Each subject
was tested with an average of 69 allergens, and 69 percent
had at least one positive reaction and half had two or more
positive reactions.
The study also confirmed that patch testing is effective for
identifying contact allergens.
Infant antibiotics use tied to
childhood asthma
Babies treated with antibiotics before 12 months old are
twice as likely to develop asthma in childhood, according to
a study in Chest. Canadian researchers at University
of British Columbia, Vancouver, reviewed seven studies made
up of 12,082 children and compared exposure to at least one
antibiotic to no exposure in the first year of life. The
team also reviewed data from five studies made up of 27,167
children, comparing antibiotic dosing. That review showed
that for each extra course of antibiotics during the first
year of life a child was 1.16 times more likely to develop
asthma.
|
| |
|
|
|
A
word from Dr. William Dolen, president
OIG Report on Allergen Immunotherapy
The ACAAI recognizes the importance of developing
standards for coverage, coding and documentation
requirements for allergen immunotherapy and allergy
testing, as recommended in a recent report by the
Department of Health and Human Services Office of
Inspector General (OIG) titled Allergen
Immunotherapy for Medicare Beneficiaries.
The OIG states in the report that it considers the
Joint Task Force recommendations to be
“professionally recognized standards of health
care.” The PDF document can be found at:
http://www.oig.hhs.gov/w-new.html
The College fully supports the consensus
recommendations made by the Joint Task Force on
Practice Parameters, which includes the
Immunotherapy and Diagnostic Testing parameters.
These recommendations were not intended for use by
third parties in setting standards of care. They are
dynamic, and periodically updated. They do provide
goals and suggestions for excellent care, and they
do offer good recommendations for documentation of
testing and immunotherapy. They are meant to be used
at the discretion of the physician according to his
or her experience; there are clinical situations in
which a recommendation may not apply to an
individual patient.
The ACAAI encourages its members to document a
course of immunotherapy in a way that would permit
third-party reviewers to recognize practice
excellence. We also recognize that unduly complex
documentation requirements would add to the cost of
a patient visit.
The ACAAI notes the important role of professionally
recognized standards of care. The College would
welcome an opportunity to work with Centers for
Medicare and Medicaid Services (CMS) to develop
workable coverage criteria that would limit the
potential for abuse of allergy diagnostic testing
and immunotherapy.
-Bill |
|
|
|
Plan to attend the
ACAAI-HSACI meeting in Greece
The ACAAI and Hellenic Society of Allergy & Clinical
Immunology (HSACI) are co-sponsoring a
Joint Allergy Symposium, Allergy Update in Greece,
Sept. 6-9, 2006, in beautiful Athens.
This international meeting brings together many of the
finest researchers and clinicians to present cutting-edge
lectures on the most important topics for the clinical
practice of allergy and immunology.
Plan to join your colleagues in Athens, one of the most
exciting cities in the world, the metropolis of wisdom,
philosophy and inspiration. The modern Athens Ledra Marriott
Hotel is the perfect venue for this meeting, with its
spacious conference center and view of the Acropolis.
|
Drugs
and Devices |
Members report shortage of
generic CFC-containing albuterol inhalers
The ACAAI has received increasing numbers of reports from its
members of
local and regional “mismatch between supply and demand” for
CFC-containing
generic albuterol inhalers. In most areas, pharmacists appear to
be
receiving what they order from the wholesalers. However, it
appears that the
CFC to HFA transition (scheduled to be complete by the end of
2008) has
begun. We understand that there is a sufficient supply of
branded CFC
albuterol, HFA formulations of albuterol and levalbuterol, and
other beta-2
adrenergic agents such as pirbuterol and metaproterenol.
FDA approves new primary
immunodeficiency treatment
The FDA has approved an immunoglobulin product for subcutaneous
use. The product, with the trade name Vivaglobin (ZLB Behring),
can be given subcutaneously on a weekly basis using an infusion
pump.
http://www.vivaglobin.com
|
Association
News |
| |
|
New
Practice Parameter reveals
complexity of food allergy
management
The Joint Task Force on Practice Parameters, representing the
ACAAI, the American Academy of Allergy, Asthma and
Immunology (AAAAI) and the Joint Council of Allergy, Asthma
and Immunology (JCAAI), has published “Food Allergy: A
Practice Parameter” this month in Annals of Allergy,
Asthma & Immunology.
“The practice parameter on food allergy represents more than
10 years of research and investigation of literature by
members of the Joint Task Force,” said Dr. Jean A. Chapman,
Cape Girardeau, Mo., a chief editor. “Designed to improve
patient care, the guidelines provide practicing physicians
with an evidence-based, broadly accepted approach to the
diagnostic evaluation and management of IgE-mediated
(allergic) food reactions.”
Components of the practice parameter include an annotated
algorithm that presents the major decision points for
evaluation of patients suspected of having food allergy;
summary statements; and sections on diagnosis and
management, which are the core of the practice parameter.
“Each summary statement in the parameter is followed by
supporting text. The text includes graded references that
document reliability, thereby assuring a better grade of
evidence,” Dr. Chapman said.
The 68-page Annals Supplement includes a detailed
discussion of skin prick or puncture tests, serologic tests
for specific IgE and oral food challenges. Sections discuss
successful avoidance, risk factors and prevention of food
allergy. Cross-reactivity of food allergy, adverse reactions
to food additives, genetically modified foods, and future
directions also are discussed. Recommendations for food
allergy management in special settings and circumstances are
included, where patients have an increased risk for
unintentional food allergy exposure.
ACAAI membership at an all-time high
The ACAAI recruited 259 new members last year, bringing its
total membership to an all-time high of 5,085. Of these, the
average age of the 205 new physician members is 36 years.
Following is a list of the
physicians who sponsored the most U.S. applications:
|
A. Wesley Burks, 7
Larry Hagan, 5
William Klaustermeyer, 5
Bryan Martin, 5
Charlotte Cunningham-Rundles, 4
Blanca E. Del Rio Navarro, 4
J. Andrew Grant, 4
James L. Baldwin, 3 |
Anita Gewurz, 3
Paul Greenberger, 3
Rhoda Kagan, 3
Jay Portnoy, 3
Sujatha Ramesh, 3
Arlene Schneider, 3
Laurianne Wild, 3 |
The states that provided
the most new members are Texas (22), California (18), New
York (17), Maryland (10), Pennsylvania (9), Missouri (9),
Colorado (7) and Ohio (7).
The College invites members who are ABAI-certified to apply
for Fellowship, using the membership application
downloadable from the
Web site.

The College honored 45 newly
elected Fellows at the 2005 Convocation.
|
|
|
Fellows-in-Training |
| |
|
Immunology Review Corner
Welcome to the Board Review Corner, prepared by Dr. Karla R.
Davis, senior representative of ACAAI’s fellows-in-training (FITs)
to the Board of Regents. The Board Review Corner is your chance
to test your Board preparedness.
To refer to a previous Board Review Corner, click the “Archive”
link in the left column.
Immunology Review Corner: Chapter 64 (Part B) of the 6th
edition of Middleton’s Allergy Principles and Practice,
edited by N. Franklin Adkinson, et al. Review questions were
written by Drs. Karla R. Davis, Walter Reed Medical Center; and Anne
K. Ellis, McMaster University.
 |
|